DEF: Corner Growth 2 Seeks Extension for Business Combination

Corner Growth Acquisition Corp. 2 is seeking shareholder approval to extend its deadline to complete a business combination from December 31, 2025, to December 31, 2026, to avoid liquidation.

Summary

• An Extraordinary General Meeting (EGM) will be held virtually on December 23, 2025, at 3:00 p.m. Eastern Time.
• The primary proposal is to amend the company's Articles of Association to extend the deadline for completing a business combination from December 31, 2025 (Current Termination Date) to December 31, 2026 (Extended Date).
• The company states it will not be able to complete an initial business combination by the current deadline and would be forced to liquidate without the extension.
• Public shareholders have the option to redeem their Class A ordinary shares for cash at an anticipated per-share price of approximately $0.25, based on the Trust Account balance of approximately $185,000 as of November 30, 2025.
• The Extension Proposal requires a special resolution (two-thirds of votes cast), but the Sponsors, who own 91.1% of outstanding ordinary shares, intend to vote in favor, making approval likely.
• An Adjournment Proposal will also be voted on, allowing the Board to adjourn the EGM if more time is needed to effectuate the Extension.
• Warrants will expire worthless if the company liquidates.

Sentiment

Score: 2

Explanation: The company is in a highly precarious position, having failed to secure a business combination after multiple extensions and experiencing significant redemptions, leading to a near-depleted Trust Account. While the extension prevents immediate liquidation, the extremely low per-share redemption value and lack of a trading market are overwhelmingly negative indicators of its operational and financial health.

Positives

• The proposed extension provides an additional year (until December 31, 2026) for the company to identify and consummate a business combination, preventing immediate liquidation.
• Public shareholders who do not redeem their shares now will retain the right to vote on a future business combination and to redeem their shares in connection with such a transaction or if the company liquidates by the extended date.
• The Sponsors' significant ownership (91.1%) and stated intention to vote for the Extension Proposal make its approval highly probable, ensuring the company avoids immediate dissolution.

Negatives

• The company has failed to complete a business combination by multiple prior deadlines, indicating persistent challenges in identifying a suitable target.
• The Trust Account balance has been severely depleted from an initial $185,000,000 to approximately $185,000 as of November 30, 2025, due to prior redemptions.
• The anticipated per-share redemption price of approximately $0.25 is a drastic reduction from the initial IPO price of $10.00, representing significant value loss for public shareholders.
• The company's securities have been delisted from the Nasdaq Stock Market and currently lack an active open market for trading, severely limiting liquidity for shareholders.
• Warrants will expire worthless if the company ultimately liquidates, regardless of the extension.

Risks

• There is no assurance that the extension will enable the company to complete an initial business combination by the Extended Date.
• Significant redemptions in connection with the Extension Proposal could further reduce the Trust Account, potentially leaving insufficient cash to complete a business combination or requiring additional, uncertain financing.
• The company faces a risk of being deemed an unregistered investment company under the Investment Company Act of 1940 due to the prolonged search for a business combination, which could force liquidation.
• If the company domesticates as a U.S. corporation prior to redemptions, it could be subject to a 1% excise tax on share repurchases under the Inflation Reduction Act, potentially reducing cash available for redemptions or contributions to a target business.
• Any proposed business combination involving a U.S. business with national security implications could be subject to review by the Committee on Foreign Investment in the United States (CFIUS), potentially delaying or blocking the transaction.
• The lack of an active trading market for the company's delisted securities could adversely affect its ability to consummate an initial business combination and limit shareholders' ability to sell their shares.
• Sponsors, directors, and officers have interests in the proposals that may differ from public shareholders, primarily due to their ownership of founder shares that would be worthless upon liquidation.

Future Outlook

If the Extension Proposal is approved, the company will continue its efforts to complete an initial business combination until December 31, 2026. It will remain a reporting company under the Securities Exchange Act of 1934, and its units, public shares, and warrants will remain publicly traded. However, the reduced Trust Account balance after redemptions may necessitate obtaining additional funds to complete a business combination, with no assurance of availability on acceptable terms.

Management Comments

• Our Board has determined that it is in the best interests of the Company and our shareholders to seek an extension of such date and have our shareholders approve the Extension Proposal to allow for additional time to consummate a business combination.
• Without the Extension, if we are unable to complete a business combination on or before December 31, 2025, we would be precluded from completing an initial business combination and, among other things, be required to cease all operations and ultimately liquidate and dissolve the Company.
• We will not be able to complete an initial business combination by such date [December 31, 2025].
• Our Board believes current circumstances warrant providing the Company with additional time to complete a business combination, particularly since we are also affording shareholders who wish to redeem their Public Shares the opportunity to do so.
• Our Sponsors own and control sufficient shares for the Extension Proposal to be approved and have indicated their intention to vote to approve the Extension Proposal, so it is likely that the Extension Proposal will be approved.

Industry Context

This filing reflects the ongoing challenges faced by Special Purpose Acquisition Companies (SPACs) in completing business combinations within their initial timelines, often necessitating multiple extensions. The company's decision to hold Trust Account funds in cash or demand deposits aligns with broader industry adjustments following the SEC's January 2024 SPAC Rules, aimed at mitigating risks of being deemed an unregistered investment company. The mention of the Inflation Reduction Act's excise tax and potential CFIUS review highlights increasing regulatory complexities and scrutiny impacting M&A activities, particularly for SPACs seeking U.S. targets or involving foreign investors.

Comparison to Industry Standards

• The company's repeated need for extensions (this being the fifth request) and significant prior redemptions, which have reduced the Trust Account from $185 million to $185,000, is significantly worse than the performance of successful SPACs that typically complete a business combination within their initial timeframe or one to two extensions.
• The anticipated per-share redemption price of approximately $0.25 is exceptionally low compared to the initial IPO price of $10.00, indicating a near-total loss of value for public shareholders who have not previously redeemed, a performance far below industry averages for SPAC liquidations or redemptions which usually return close to the IPO price plus accrued interest.
• The delisting from Nasdaq and the absence of an active trading market for its securities place the company in a distressed category, contrasting sharply with the liquidity and market access expected of publicly traded entities and making it a less attractive acquisition vehicle.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• IPO Sponsor agreed to deposit funds into the Trust Account for previous extensions to support the company's operations.
• A Purchase Agreement on August 15, 2024, involved IPO Sponsor transferring 2,685,000 Class A Ordinary Shares to New Sponsor, IPO Sponsor canceling 4,950,000 private placement warrants, and certain creditors agreeing to cancel or reduce amounts owed by the company, assigning remaining liability to the Sponsor.
• Cantor Fitzgerald & Co., the IPO underwriter, agreed to accept a certain number of company shares post-business combination in lieu of deferred cash commissions owed from the IPO.
• Sponsors, directors, and officers have interests in the proposals, including ownership of founder shares (acquired for an aggregate of $25,000) which would be worthless upon liquidation, and the possibility of future compensatory arrangements.

Stakeholder Impact

• **Public Shareholders**: Face a decision to redeem shares at a significantly reduced price ($0.25/share) or hold for a highly uncertain future business combination. Their warrants are at risk of expiring worthless. The lack of a trading market limits their exit options.
• **Sponsors/Founder Shareholders**: Have a strong incentive to approve the extension to prevent their founder shares (acquired for $25,000) from becoming worthless. They maintain significant control over voting outcomes.
• **Warrant Holders**: Their warrants will expire worthless if the company liquidates, regardless of the extension, unless a business combination is successfully completed.
• **Creditors**: The company has obligations under Cayman Islands law to provide for claims of creditors upon liquidation, which could potentially reduce the per-share distribution from the Trust Account.
• **Management/Directors**: Their out-of-pocket expenses incurred on the company's behalf may not be reimbursed if the company liquidates without sufficient funds outside the Trust Account. Their continued roles are contingent on the company's survival.

Next Steps

• Shareholders are urged to vote on the Extension Proposal and Adjournment Proposal at the Extraordinary General Meeting on December 23, 2025.
• Public shareholders wishing to redeem their shares must do so by 5:00 p.m. Eastern Time on December 18, 2025.
• If the Extension Proposal is approved, the company will continue its efforts to complete a business combination by December 31, 2026.
• If the Extension Proposal is not approved, the company will cease operations, liquidate, and dissolve.

Key Dates

Recommendation

The company's history of multiple extensions, severely depleted Trust Account (from $185M to $0.185M), and an anticipated per-share redemption value of only $0.25 indicate a highly distressed situation. Its securities are delisted and lack an active trading market, severely limiting liquidity. While the extension prevents immediate liquidation, the probability of finding a value-accretive business combination, given the company's track record and minimal remaining capital, appears extremely low. Public shareholders are advised to redeem their shares now to recover the minimal remaining value, as holding on presents significant downside risk (warrants expiring worthless, further claims on the Trust Account) with very little realistic upside.

Keywords

SPAC, business combination, extension, proxy statement, redemption, liquidation, Trust Account, corporate governance, SEC filing, Class A ordinary shares, warrants, Cayman Islands, Investment Company Act, Inflation Reduction Act, CFIUS